CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Candida - oral - Management
Which scenario?
- Scenario: Diagnosis: covers the diagnosis and differential diagnosis of oral candidiasis in people of all ages.
- Scenario: Children: covers the management of oral candidiasis in infants and children younger than 16 years of age.
- Scenario: Adults (not immunocompromised): covers the management of oral candidiasis in people 16 years of age or older who are not markedly immunocompromised, including people who have diabetes, use inhaled corticosteroids, or wear dentures.
- Scenario: Adults (immunosuppressive treatment): covers the management of oral candidiasis in adults who are receiving treatment that may cause immunosuppression, including oral corticosteroids, disease-modifying anti-rheumatic drugs (DMARDs), and chemotherapy and/or radiotherapy.
- Scenario: Adults (HIV positive): covers the management of people who have oral candidiasis and who are HIV-positive.
© NHS Institute for Innovation and Improvement